People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery.

Researchers have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for atrial fibrillation (AF) patients.

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is according to a new study, "Mitral annular disjunction ...

As you can see from the chart above the percentage of shares that are sold short for Axis Capital Holdings has declined since its last report. This does not mean that the stock is going to rise in ...

US pop singer Ariana Grande sings about leaving her heart in a London pub before being physically stitched back together in a new short film. The track Hampstead, one of six new tracks on the ...

Yes — if you’re sitting on extra cash and would like a safe place to stash it at a decent interest rate. The latest: The top rates on online bank accounts, money market mutual funds, and short ...

India has developed its first indigenous MRI machine to be installed at AIIMS Delhi by October for trials, reducing dependency on imports by 80-85%. An MoU was signed with SAMEER for the installation.

“I had a full-body MRI just for fun. No symptoms whatsoever,” Sarah Blackburn shared in a viral TikTok, recounting her shocking experience earlier this year after getting a Prenuvo sca ...

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a new study.

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular disease, excluding Greater China. Merck has entered an exclusive licensing ...

The Axis Ultra Short Duration Fund Direct Growth has an AUM of 5594.59 crores & has delivered CAGR of 6.32% in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 0.36%.

However, its effectiveness is hindered by the inability to reliably discriminate between the risk of SCD and competing death of heart failure deterioration ... Cardiac long-axis view and short-axis ...